198 related articles for article (PubMed ID: 9741739)
1. Short-term and long-term inhibition of endogenous atrial natriuretic peptide in dogs with early-stage heart failure.
Fukai D; Wada A; Tsutamoto T; Kinoshita M
Jpn Circ J; 1998 Aug; 62(8):604-10. PubMed ID: 9741739
[TBL] [Abstract][Full Text] [Related]
2. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors.
Wada A; Tsutamoto T; Matsuda Y; Kinoshita M
Circulation; 1994 May; 89(5):2232-40. PubMed ID: 7910118
[TBL] [Abstract][Full Text] [Related]
3. A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction.
Stevens TL; Burnett JC; Kinoshita M; Matsuda Y; Redfield MM
J Clin Invest; 1995 Mar; 95(3):1101-8. PubMed ID: 7883958
[TBL] [Abstract][Full Text] [Related]
4. Atrial natriuretic peptide in congestive heart failure in the dog: plasma levels, cyclic guanosine monophosphate, ultrastructure of atrial myoendocrine cells, and hemodynamic, hormonal, and renal effects.
Riegger GA; Elsner D; Kromer EP; Daffner C; Forssmann WG; Muders F; Pascher EW; Kochsiek K
Circulation; 1988 Feb; 77(2):398-406. PubMed ID: 2962788
[TBL] [Abstract][Full Text] [Related]
5. Role of endogenous atrial natriuretic peptide in chronic anemia in the ovine fetus: effects of a non-peptide antagonist for atrial natriuretic peptide receptor.
Silberbach M; Woods LL; Hohimer AR; Shiota T; Matsuda Y; Davis LE
Pediatr Res; 1995 Nov; 38(5):722-8. PubMed ID: 8552440
[TBL] [Abstract][Full Text] [Related]
6. Endogenous natriuretic peptides participate in renal and humoral actions of acute vasopeptidase inhibition in experimental mild heart failure.
Chen HH; Lainchbury JG; Matsuda Y; Harty GJ; Burnett JC
Hypertension; 2001 Aug; 38(2):187-91. PubMed ID: 11509474
[TBL] [Abstract][Full Text] [Related]
7. Possible regulation of renin release by ANP in dogs with heart failure.
Kanamori T; Wada A; Tsutamoto T; Kinoshita M
Am J Physiol; 1995 Jun; 268(6 Pt 2):H2281-7. PubMed ID: 7611478
[TBL] [Abstract][Full Text] [Related]
8. Renal role of the endogenous natriuretic peptide system in acute congestive heart failure.
Stevens TL; Rasmussen TE; Wei CM; Kinoshita M; Matsuda Y; Burnett JC
J Card Fail; 1996 Jun; 2(2):119-25. PubMed ID: 8798113
[TBL] [Abstract][Full Text] [Related]
9. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor.
Hirata Y; Matsuoka H; Suzuki E; Hayakawa H; Sugimoto T; Matsuda Y; Morishita Y; Kangawa K; Minamino N; Matsuo H
Circulation; 1993 Feb; 87(2):554-61. PubMed ID: 8381060
[TBL] [Abstract][Full Text] [Related]
10. Renal response to acute neutral endopeptidase inhibition in mild and severe experimental heart failure.
Chen HH; Schirger JA; Chau WL; Jougasaki M; Lisy O; Redfield MM; Barclay PT; Burnett JC
Circulation; 1999 Dec; 100(24):2443-8. PubMed ID: 10595958
[TBL] [Abstract][Full Text] [Related]
11. Hemodynamic changes and renal plasma flow in early heart failure: implications for renin, aldosterone, norepinephrine, atrial natriuretic peptide and prostacyclin.
Holmer SR; Riegger AJ; Notheis WF; Kromer EP; Kochsiek K
Basic Res Cardiol; 1987; 82(2):101-8. PubMed ID: 2955780
[TBL] [Abstract][Full Text] [Related]
12. Natriuretic peptide analogues with distinct vasodilatory or renal activity: integrated effects in health and experimental heart failure.
Rademaker MT; Scott NJA; Koh CY; Kini RM; Richards AM
Cardiovasc Res; 2021 Jan; 117(2):508-519. PubMed ID: 32167565
[TBL] [Abstract][Full Text] [Related]
13. M-atrial natriuretic peptide and nitroglycerin in a canine model of experimental acute hypertensive heart failure: differential actions of 2 cGMP activating therapeutics.
McKie PM; Cataliotti A; Ichiki T; Sangaralingham SJ; Chen HH; Burnett JC
J Am Heart Assoc; 2014 Jan; 3(1):e000206. PubMed ID: 24385449
[TBL] [Abstract][Full Text] [Related]
14. Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure.
Rademaker MT; Charles CJ; Kosoglou T; Protter AA; Espiner EA; Nicholls MG; Richards AM
Am J Physiol; 1997 Nov; 273(5):H2372-9. PubMed ID: 9374774
[TBL] [Abstract][Full Text] [Related]
15. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism.
Borgeson DD; Stevens TL; Heublein DM; Matsuda Y; Burnett JC
Clin Sci (Lond); 1998 Aug; 95(2):195-202. PubMed ID: 9680502
[TBL] [Abstract][Full Text] [Related]
16. BNP: pathophysiological and potential therapeutic roles in acute congestive heart failure.
Grantham JA; Borgeson DD; Burnett JC
Am J Physiol; 1997 Apr; 272(4 Pt 2):R1077-83. PubMed ID: 9140004
[TBL] [Abstract][Full Text] [Related]
17. Chronic effects of ANG II antagonist in heart failure: improvement of cGMP generation from ANP.
Maeda Y; Wada A; Tsutamoto T; Fukai D; Kinoshita M
Am J Physiol; 1997 May; 272(5 Pt 2):H2139-45. PubMed ID: 9176279
[TBL] [Abstract][Full Text] [Related]
18. Endogenous atrial natriuretic peptide inhibits endothelin-1 secretion in dogs with severe congestive heart failure.
Wada A; Tsutamato T; Maeda Y; Kanamori T; Matsuda Y; Kinoshita M
Am J Physiol; 1996 May; 270(5 Pt 2):H1819-24. PubMed ID: 8928891
[TBL] [Abstract][Full Text] [Related]
19. Atrial natriuretic peptide response to rapid atrial pacing in cardiac-denervated dogs.
Williams TD; Walsh KP; Canepa-Anson R; Noble MI; Drake-Holland AJ; Sutton R; Lightman SL
Am J Physiol; 1989 Jul; 257(1 Pt 2):R162-7. PubMed ID: 2526592
[TBL] [Abstract][Full Text] [Related]
20. Atrial natriuretic peptide and sodium homeostasis in compensated heart failure.
Lohmeier TE; Mizelle HL; Reinhart GA; Montani JP; Hord CE; Didlake RH
Am J Physiol; 1996 Nov; 271(5 Pt 2):R1353-63. PubMed ID: 8945974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
